Biomaterials

Journal

Publication Venue For

  • Optoacoustic imaging identifies ovarian cancer using a microenvironment targeted theranostic wormhole mesoporous silica nanoparticle.  182:114-126. 2018
  • Islet encapsulation with polyphenol coatings decreases pro-inflammatory chemokine synthesis and T cell trafficking.  128:19-32. 2017
  • Functional engineered human cardiac patches prepared from nature's platform improve heart function after acute myocardial infarction.  105:52-65. 2016
  • KE108-conjugated unimolecular micelles loaded with a novel HDAC inhibitor thailandepsin-A for targeted neuroendocrine cancer therapy.  97:22-33. 2016
  • Thailandepsin A-loaded and octreotide-functionalized unimolecular micelles for targeted neuroendocrine cancer therapy.  91:1-10. 2016
  • Nanofibrous clinical-grade collagen scaffolds seeded with human cardiomyocytes induces cardiac remodeling in dilated cardiomyopathy.  80:157-168. 2016
  • Controlled and targeted release of antigens by intelligent shell for improving applicability of oral vaccines.  77:307-319. 2016
  • Diversity in the utilization of glucose and lactate in synthetic mammalian myotubes generated by engineered configurations of MyoD and E12 in otherwise non-differentiation growth conditions.  43:50-60. 2015
  • The influence of a spatiotemporal 3D environment on endothelial cell differentiation of human induced pluripotent stem cells.  35:3786-3793. 2014
  • Myocardial contraction and hyaluronic acid mechanotransduction inepithelial-to-mesenchymal transformation of endocardial cells.  35:2809-2815. 2014
  • Heterogeneity of myotubes generated by the MyoD and E12 basic helix-loop-helix transcription factors in otherwise non-differentiation growth conditions.  35:2188-2198. 2014
  • Hemostatic properties and the role of cell receptor recognition in human hair keratin protein hydrogels.  34:2632-2640. 2013
  • Engineering nanocages with polyglutamate domains for coupling to hydroxyapatite biomaterials and allograft bone.  34:2455-2462. 2013
  • Polyglutamate directed coupling of bioactive peptides for the delivery of osteoinductive signals on allograft bone.  34:1506-1513. 2013
  • Increasing the pore sizes of bone-mimetic electrospun scaffolds comprised of polycaprolactone, collagen I and hydroxyapatite to enhance cell infiltration.  33:524-534. 2012
  • Enhanced osseointegration of titanium implant through the local delivery of transcription factor SATB2.  32:8676-8683. 2011
  • Mechanisms of hepatocyte attachment to keratin biomaterials.  32:7555-7561. 2011
  • Critical-size calvarial bone defects healing in a mouse model with silk scaffolds and SATB2-modified iPSCs.  32:5065-5076. 2011
  • Advantages of RGD peptides for directing cell association with biomaterials.  32:4205-4210. 2011
  • Cell infiltration and growth in a low density, uncompressed three-dimensional electrospun nanofibrous scaffold.  32:1583-1590. 2011
  • Mechanical and biological properties of keratose biomaterials.  32:8205-8217. 2011
  • Enhancement of peptide coupling to hydroxyapatite and implant osseointegration through collagen mimetic peptide modified with a polyglutamate domain.  31:9586-9594. 2010
  • A polydioxanone electrospun valved patch to replace the right ventricular outflow tract in a growing lamb model.  31:4056-4063. 2010
  • An in vitro regenerated functional human endothelium on a nanofibrous electrospun scaffold.  31:4376-4381. 2010
  • A nitric oxide releasing, self assembled peptide amphiphile matrix that mimics native endothelium for coating implantable cardiovascular devices.  31:1502-1508. 2010
  • Mandibular repair in rats with premineralized silk scaffolds and BMP-2-modified bMSCs.  30:4522-4532. 2009
  • The effect of collagen I mimetic peptides on mesenchymal stem cell adhesion and differentiation, and on bone formation at hydroxyapatite surfaces.  30:1898-1909. 2009
  • Mesenchymal stem cell interaction with ultra-smooth nanostructured diamond for wear-resistant orthopaedic implants.  29:3461-3468. 2008
  • The effect of RGD peptides on osseointegration of hydroxyapatite biomaterials.  29:3075-3083. 2008
  • The effect of adsorbed serum proteins, RGD and proteoglycan-binding peptides on the adhesion of mesenchymal stem cells to hydroxyapatite.  28:383-392. 2007
  • Osteoblast adhesion and matrix mineralization on sol-gel-derived titanium oxide.  27:2201-2212. 2006
  • The effect of the addition of a polyglutamate motif to RGD on peptide tethering to hydroxyapatite and the promotion of mesenchymal stem cell adhesion.  26:7046-7056. 2005
  • Regulation of mesenchymal stem cell attachment and spreading on hydroxyapatite by RGD peptides and adsorbed serum proteins.  26:1467-1475. 2005
  • Animal models for intestinal tissue engineering.  25:1675-1681. 2004
  • A hybrid zinc-calcium-silicate polyalkenoate bone cement.  24:2749-2757. 2003
  • Compressive strength, fluoride release and recharge of fluoride-releasing materials.  24:2451-2461. 2003
  • The effect of virtual cross linking on the oxidative stability and lipid uptake of aliphatic poly(urethane urea).  23:273-282. 2002
  • Polypropylene fumarate/phloroglucinol triglycidyl methacrylate blend for use as partially biodegradable orthopaedic cement.  22:2749-2757. 2001
  • The effect of solvent extraction and sterilization procedure on the tissue response to Dacron® velour.  20:129-136. 1999
  • Non-epidermally induced failure modes of percutaneous devices.  6:352-356. 1985
  • Electron microscope investigation of soft tissue ingrowth into Dacron® velour with dogs.  4:105-111. 1983
  • International Standard Serial Number (issn)

  • 0142-9612
  • Electronic International Standard Serial Number (eissn)

  • 1878-5905